TY - JOUR
T1 - Yersinia pestis Interacts With SIGNR1 (CD209b) for Promoting Host Dissemination and Infection
AU - Yang, Kun
AU - He, Yingxia
AU - Park, Chae Gyu
AU - Kang, Young Sun
AU - Zhang, Pei
AU - Han, Yanping
AU - Cui, Yujun
AU - Bulgheresi, Silvia
AU - Anisimov, Andrey P
AU - Dentovskaya, Svetlana V
AU - Ying, Xiaoling
AU - Jiang, Lingyu
AU - Ding, Honghui
AU - Njiri, Olivia Adhiambo
AU - Zhang, Shusheng
AU - Zheng, Guoxing
AU - Xia, Lianxu
AU - Kan, Biao
AU - Wang, Xin
AU - Jing, Huaiqi
AU - Yan, Meiying
AU - Li, Wei
AU - Wang, Yuanzhi
AU - Xiamu, Xiding
AU - Chen, Gang
AU - Ma, Ding
AU - Bartra, Sara Schesser
AU - Plano, Gregory V
AU - Klena, John D
AU - Yang, Ruifu
AU - Skurnik, Mikael
AU - Chen, Tie
N1 - Publisher Copyright:
Copyright © 2019 Yang, He, Park, Kang, Zhang, Han, Cui, Bulgheresi, Anisimov, Dentovskaya, Ying, Jiang, Ding, Njiri, Zhang, Zheng, Xia, Kan, Wang, Jing, Yan, Li, Wang, Xiamu, Chen, Ma, Bartra, Plano, Klena, Yang, Skurnik and Chen.
PY - 2019
Y1 - 2019
N2 - Yersinia pestis, a Gram-negative bacterium and the etiologic agent of plague, has evolved from Yersinia pseudotuberculosis, a cause of a mild enteric disease. However, the molecular and biological mechanisms of how Y. pseudotuberculosis evolved to such a remarkably virulent pathogen, Y. pestis, are not clear. The ability to initiate a rapid bacterial dissemination is a characteristic hallmark of Y. pestis infection. A distinguishing characteristic between the two Yersinia species is that Y. pseudotuberculosis strains possess an O-antigen of lipopolysaccharide (LPS) while Y. pestis has lost the O-antigen during evolution and therefore exposes its core LPS. In this study, we showed that Y. pestis utilizes its core LPS to interact with SIGNR1 (CD209b), a C-type lectin receptor on antigen presenting cells (APCs), leading to bacterial dissemination to lymph nodes, spleen and liver, and the initiation of a systemic infection. We therefore propose that the loss of O-antigen represents a critical step in the evolution of Y. pseudotuberculosis into Y. pestis in terms of hijacking APCs, promoting bacterial dissemination and causing the plague.
AB - Yersinia pestis, a Gram-negative bacterium and the etiologic agent of plague, has evolved from Yersinia pseudotuberculosis, a cause of a mild enteric disease. However, the molecular and biological mechanisms of how Y. pseudotuberculosis evolved to such a remarkably virulent pathogen, Y. pestis, are not clear. The ability to initiate a rapid bacterial dissemination is a characteristic hallmark of Y. pestis infection. A distinguishing characteristic between the two Yersinia species is that Y. pseudotuberculosis strains possess an O-antigen of lipopolysaccharide (LPS) while Y. pestis has lost the O-antigen during evolution and therefore exposes its core LPS. In this study, we showed that Y. pestis utilizes its core LPS to interact with SIGNR1 (CD209b), a C-type lectin receptor on antigen presenting cells (APCs), leading to bacterial dissemination to lymph nodes, spleen and liver, and the initiation of a systemic infection. We therefore propose that the loss of O-antigen represents a critical step in the evolution of Y. pseudotuberculosis into Y. pestis in terms of hijacking APCs, promoting bacterial dissemination and causing the plague.
KW - CAPSULAR POLYSACCHARIDE
KW - CORE LIPOPOLYSACCHARIDE
KW - DC-SIGN
KW - DENDRITIC CELLS
KW - ESCHERICHIA-COLI
KW - LIPOPOLYSACCHARIDE O-ANTIGEN
KW - MEDIATES UPTAKE
KW - NEISSERIA-GONORRHOEAE
KW - NONINTEGRIN CD209
KW - RFB GENE-CLUSTER
KW - SIGNR1 (CD209b)
KW - Yersinia pestis
KW - antigen presenting cells (APCs)
KW - bacterial dissemination
KW - core lipopolysaccharide/lipooligosaccharides (core LPS/LOS)
KW - dendritic cells (DCs)
KW - host-pathogen interactions
KW - macrophages
KW - Dendritic cells (DCs)
KW - Bacterial dissemination
KW - Macrophages
KW - Host-pathogen interactions
KW - Antigen presenting cells (APCs)
KW - Core lipopolysaccharide/lipooligosaccharides (core LPS/LOS)
UR - http://www.scopus.com/inward/record.url?scp=85063935356&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2019.00096
DO - 10.3389/fimmu.2019.00096
M3 - Article
C2 - 30915064
SN - 1664-3224
VL - 10
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 96
ER -